Replimune (REPL) Return on Equity [ROE] (2018 - 2026)
Replimune (REPL) reported Return on Equity [ROE] of -217.10% for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 142.49 percentage points from -74.61% a year earlier and down 50.73 percentage points from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Return on Equity [ROE] (2018 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Replimune posted Return on Equity [ROE] of -108.07%, down 45.61 percentage points from FY2025.
- Return on Equity [ROE] has declined for five consecutive fiscal years, with a five-year change of -84.67 percentage points (FY2021 to FY2026).
- By fiscal year, Return on Equity [ROE] came in at -62.46% in FY2025 (-16.13 pp), -46.33% in FY2024 (-10.32 pp), -36.00% in FY2023 (-10.06 pp) and -25.94% in FY2022 (-2.54 pp).
- The fiscal Q1 2027 figure ranks as the lowest quarterly Return on Equity [ROE] in data going back to fiscal Q2 2019.
- Year over year, Return on Equity [ROE] has now declined in each of the last 19 quarters, with an average year-over-year change of -52.79 percentage points over the last eight quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was fiscal Q2 2022 (a gain of 4.75 percentage points); the low point was fiscal Q1 2027 (a drop of 142.49 percentage points).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at -166.37% (Q4 2026), -132.66% (Q3 2026) and -103.25% (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | - |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 22.24% |
| 10 | Replimune | 1.09 Bn | 1.09 Bn | - | -217.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -217.10% |
| Mar 31, 2026 | -166.37% |
| Dec 31, 2025 | -132.66% |
| Sep 30, 2025 | -103.25% |
| Jun 30, 2025 | -74.61% |
| Mar 31, 2025 | -55.07% |
| Dec 31, 2024 | -52.84% |
| Sep 30, 2024 | -52.73% |
| Jun 30, 2024 | -54.94% |
| Mar 31, 2024 | -54.22% |
| Dec 31, 2023 | -47.37% |
| Sep 30, 2023 | -40.55% |
| Jun 30, 2023 | -33.97% |
| Mar 31, 2023 | -30.30% |
| Dec 31, 2022 | -32.04% |
| Sep 30, 2022 | -36.97% |
| Jun 30, 2022 | -32.35% |
| Mar 31, 2022 | -27.79% |
| Dec 31, 2021 | -24.17% |
| Sep 30, 2021 | -21.13% |
API Access
Replimune Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();